

Cover Story
Conversation with The Cancer Letter
By Matthew Bin Han Ong
“I think cell therapy is going to continue to be a very, very important treatment modality for cancer, and we would like to see the Tampa Bay area become the cell therapy capital of the universe,” Hwu, the new president and CEO of H. Lee Moffitt Cancer Center, said to The Cancer Letter.
By Alexandria Carolan and Matthew Bin Han Ong
By Alexandria Carolan
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored
















